Continuing Medical Education webinars focusing on various topics related to the pandemic. These town halls are available for AMA PRA Category 1 Credit™ and can be accessed here.
SARS-CoV-2 Virus Biology & Vaccine Development
More details can be found in this flyer.
Scott S. Terhune, PhD
The session on SARS-CoV-2 Virus Biology & Vaccine Development will focus on defining the physical features of SARS-CoV-2 viral particle and its replication cycle. It will include critical information relating to what determines viral infectivity outside of the human body and what are the pieces of the virus being used for vaccine development. We will also discuss essential steps used by SARS-CoV-2 during its replication that are plausible targets for effective antiviral development. Understanding the fundamental aspects of SARS-CoV-2 replication is necessary for educating others on therapeutic strategies and public health recommendations.
The Current State of Therapeutics
J. Njeri Wainaina, MD, FACP
The treatment of COVID-19 has evolved over time as we have gained understanding of disease process and the effectiveness of potential interventions. This session will provide an overview of the key therapeutics that are available now and emerging from the pipeline.
Communicability and Public Health Response
Laura D. Cassidy, MS, PhD
This presentation will describe some basic epidemiologic principles such as the transmission of disease, period of infectiousness, exposure and risk, determinants of health, containment and control and provide some statistics and trends about the virus in Wisconsin.
The Convergence of Seasonal Flu and SARS-CoV-2
Mary Beth Graham, MD, FIDSA, FACP
This presentation focuses on the two most significant pandemics in the past century and how understanding the history of influenza may provide insights into what to expect in the future with SARS-CoV-2.
Combating COVID-19 Challenges in Disadvantaged Populations – a Case Study
Michelle Minikel, MD
Green Bay was one of the earliest hotspots of the SARS-CoV2 pandemic due to large outbreaks in several meatpacking plants in April and May of 2020. This early surge disproportionately affected patients of color and patients with limited English proficiency. We will review some of the measures that our clinic, Bellin’s Clinica Hispana, took with regards to testing and communication of results that were helpful in serving this population as well as some of the aspects of care that need to be improved to better serve “disadvantaged populations” in a public health crisis. Current medical literature on this topic will also be incorporated and we will close by touching on the larger ramifications of this pandemic as they relate to underserved patients.